Incremento en la detección de mutaciones del gen NF2 en Meningiomas y Neurinomas mediante el análisis del Polimorfismo en la conformación de la cadena sencilla (SSCP) del ADN

Leone, Paola E; Bello, María Josefa; Rey, Juan A; Nebreda, Paloma; Pestaña, Angel; Paz Y Miño, César.
Metro cienc ; 6(3): 23-8, nov. 1997. tab
Artículo en Español | LILACS | ID: lil-249786

Documentos relacionados

  1. Long-term outcomes of stereotactic radiosurgery for intracranial schwannoma in neurofibromatosis type 2: a genetic analysis perspective.
  2. [Schwannoma, Neurofibromatosis Type 2, and Schwannomatosis in the 2021 WHO Classification of Tumors of the Central Nervous System].
  3. [Current Topics on Precision Medicine for Neurofibromatosis Type 2].
  4. Management of neurofibromatosis type 2 and schwannomatosis associated peripheral and intraspinal schwannomas: influence of surgery, genetics, and localization.
  5. Sustained response to bevacizumab in a patient with mosaic neurofibromatosis type 2 carrying the <i>NF2</i>:c.784C>T p.(Arg262*) variant.
  6. Regression of a spinal schwannoma after Pomalidomide.
  7. Novel patient-derived xenograft and cell line models for therapeutic screening in NF2-associated schwannoma.
  8. Schwannomatosis: a Realm Reborn: year one.
  9. Updated protocol for genetic testing, screening and clinical management of individuals at risk of NF2-related schwannomatosis.
  10. What to know about schwannomatosis: a literature review.